Scientists at the @US_FDA said that the likely benefits of giving the @pfizer/BioNTech #COVID19 #vaccine to 5 to 11 year olds clearly outweigh the risks of rare cases of heart inflammation.https://t.co/zHs5AHJkUT

— The Jerusalem Post (@Jerusalem_Post) October 23, 2021